140mg

Ibrutix

Ibrutix Capsule 140mg

Ibrutinib

Himmel Pharmaceuticals Private Limited

Drug Identity

Active Ingredient
Ibrutinib
Drug Class
Antineoplastics
ATC Code
L01EL01
Status
Essential Medicine

What is Ibrutix?

Uses
Monjuvi is used to treat diffuse large B-cell lymphoma (DLBCL ) in combination with lenalidomide that is relapsed or refractory (r/r), or...

How to Take It

Dosage information not available for this product.

Safety Alerts

Before you receive Monjuvi, tell your healthcare provider about all of your medical conditions, including if you: have an active infection or have had one recently are pregnant or plan to become pregnant are breastfeeding or plan to breastfeed

Important Warnings

History of congenital short QT syndrome, increased lymphocytes
increased risk of leukostasis, monitor closely, patients at risk from further shortening of QTc interval, personal history of congenital short QT syndrome, risk of haemorrhagic events, withhold treatment for at least 3 to 7 days before and after surgery depending on risk of bleeding

Side Effects

ArrhythmiasarthralgiaCNS haemorrhageconstipationdiarrhoeadizzinessfeverhaemorrhageheadachehypertensionhyperuricaemiaincreased leucocytesincreased risk of infectioninterstitial lung diseasemuscle spasms

Drug Interactions

Antacids
Antiarrhythmics (dronedarone)
Antiepileptics (carbamazepine
fosphenytoin
phenobarbital
phenytoin
primidone)
Antifungals

Pregnancy & Lactation

Pregnancy
Avoid unless essential
Lactation
Avoid. Discontinue breast-feeding.

Price Intelligence

Rs 248,207.37
DRAP approved maximum price · per pack of 120 · approved 29 Jul, 2026
No retail price observed for this pack. Retailers may not exceed the approved maximum.
Prices across sources
DRAPper pack of 120Rs 248,207.37

Should you consider an alternative?

Other options containing Ibrutinib, and what they are not.

Identical active ingredient at the same strength. Cheapest per unit first.

Ordered by lowest price per unit where a pack size is known, then by price. Order is never affected by sponsorship. Not medical advice — confirm any change with your pharmacist or doctor.

For pharma professionalsCompany, market and opportunity intelligence

Prices as of 30 July 2026 · DRAP ceiling as of 30 July 2026 · schema v3-SKU

For medicine intelligence and professional reference only. Not medical advice.